Bioblast Pharma Ltd. (ORPN) dipped -5.2% or -0.14 to $2.55. It is about 153846 shares traded, which is 35.24% compare to the average total volume 436597. The market cap of ORPN is $8.52 million. The year to date change is 21.17%. The 52 week price range is from $1.49 to $5.99. Price of ORPN have changed -6.47% during last week. It have changed -11.41% over last month, 12.82% over last 3 months, -13.43% over last 6 months and -49.23% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORPN is 2.64. It is 3.53% above current price. The 200-day Moving Averages for ORPN is 2.58. It is 1.18% above current price. The 52-week High is 5.99. It is 134.90% from the current price. The 52-week Low is 1.49. It is -41.57% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ORPN is 0.27 on 2018-01-31. Short % to float is 4.79%. There are some statistics of ORPN. It is has market cap $8.52 million. The share outstanding is 3.34 million. The average volume is 436597. The percent of top 15 Institution holding is 4.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORPN is -111.78%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORPN is -95.72%.